Travere Therapeutics Inc. (TVTX) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Travere Therapeutics Inc.

    NASDAQ: TVTX · Real-Time Price · USD
    24.64
    0.42 (1.73%)
    At close: Oct 03, 2025, 3:59 PM
    24.00
    -2.60%
    After-hours: Oct 03, 2025, 06:30 PM EDT

    Travere Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -4.27 -5.99 -4.81 -10.31
    PEG Ratio
    		 -0.02 0.09 -0.11 0.67
    PS Ratio
    		 5.89 4.60 6.32 8.16
    PB Ratio
    		 23.26 3.32 31.29 6.15
    P/FCF Ratio
    		 -4.06 -2.07 -6.24 -47.69
    P/OCF Ratio
    		 -5.79 -2.38 -7.2 -125.55
    OCF/S Ratio
    		 -1.02 -1.93 -0.88 -0.07
    Debt / Equity Ratio
    		 6.80 2.02 9.51 0.87
    Quick Ratio
    		 2.04 3.41 3.37 4.64
    Current Ratio
    		 2.08 3.47 3.42 4.70
    Asset Turnover
    		 0.39 0.18 0.32 0.29
    Interest Coverage
    		 -28.67 -33.24 -22.84 -7.09
    Return on Equity
    		 -5.44 -0.55 -6.5 -0.6
    Return on Assets
    		 -0.54 -0.14 -0.41 -0.23
    Return on Invested Capital
    		 -0.69 -0.61 -0.47 -0.21
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 0.97 0.92 0.96 0.97
    Net Profit Margin
    		 -1.38 -0.77 -1.31 -0.79
    Pretax Profit Margin
    		 -1.37 -2.59 -1.31 -0.79
    Operating Profit Margin
    		 -1.38 -2.59 -1.19 -0.61
    FCF Margin
    		 -1.45 -2.22 -1.01 -0.17
    EBITDA Margin
    		 -1.14 -2.25 -1.41 -0.82

    Add to Watchlist